Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
transcription factor CP2 | 0.650 | 0.385 | 3.6E-06 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
DIX domain containing 1 | 0.647 | 0.385 | 7.3E-11 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
oxytocin/neurophysin I prepropeptide | 0.615 | 0.423 | 0.71 |
|
disease | 0.300 | None | 1.000 | 3 | 0 | 2009 | 2011 | ||||||||
|
phospholysine phosphohistidine inorganic pyrophosphate phosphatase | 0.716 | 0.423 | 1.6E-07 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2009 | 2016 | ||||||||
|
5-hydroxytryptamine receptor 3B | 0.678 | 0.423 | 2.5E-07 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2006 | 2008 | ||||||||
|
colony stimulating factor 2 receptor subunit beta | 0.705 | 0.423 | 0.18 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
dopamine receptor D5 | 0.603 | 0.423 | 1.3E-16 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2001 | 2004 | ||||||||
|
cardiomyopathy associated 5 | 0.711 | 0.423 | 1.3E-54 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
glutamate ionotropic receptor kainate type subunit 4 | 0.678 | 0.423 | 0.11 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2012 | 2017 | ||||||||
|
neuropeptide Y receptor Y1 | 0.628 | 0.423 | 4.3E-02 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 1998 | 1998 | ||||||||
|
adenylate cyclase 7 | 0.656 | 0.462 | 9.5E-07 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2006 | 2012 | ||||||||
|
coiled-coil and C2 domain containing 1A | 0.628 | 0.462 | 8.5E-03 |
|
disease | 0.310 | None | 0.500 | 2 | 0 | 2010 | 2010 | ||||||||
|
myelin transcription factor 1 like | 0.659 | 0.462 | 1.00 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2010 | 2012 | ||||||||
|
inter-alpha-trypsin inhibitor heavy chain 1 | 0.691 | 0.462 | 2.1E-31 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
glycosyltransferase 8 domain containing 1 | 0.711 | 0.462 | 1.1E-08 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
vesicle associated membrane protein 2 | 0.650 | 0.462 | 0.89 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
corticotropin releasing hormone binding protein | 0.659 | 0.500 | 0.21 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
5-hydroxytryptamine receptor 7 | 0.592 | 0.500 | 4.5E-02 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
karyopherin subunit alpha 3 | 0.736 | 0.500 | 0.95 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
NADH:ubiquinone oxidoreductase core subunit V2 | 0.610 | 0.500 | 5.6E-03 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2008 | 2016 | ||||||||
|
solute carrier family 17 member 6 | 0.678 | 0.500 | 0.16 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
cholecystokinin A receptor | 0.615 | 0.500 | 4.0E-03 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
QKI, KH domain containing RNA binding | 0.617 | 0.500 | 0.75 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
glutamate metabotropic receptor 7 | 0.628 | 0.538 | 1.00 |
|
disease | 0.340 | None | 0.800 | 5 | 0 | 2010 | 2018 | ||||||||
|
5-hydroxytryptamine receptor 3A | 0.608 | 0.538 | 1.7E-10 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2006 | 2017 |